REFRACTORY LEUKEMIA
Clinical trials for REFRACTORY LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Drug combo aims to wipe out Hard-to-Treat leukemia
Disease control Recruiting nowThis study tests whether adding a new drug called roginolisib to two standard drugs (venetoclax and rituximab) is safe and works better for people with chronic lymphocytic leukemia (CLL) that has come back or not responded to prior treatments. About 64 adults who have already tri…
Matched conditions: REFRACTORY LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Jennifer R. Brown, MD, PhD • Aim: Disease control
Last updated May 17, 2026 03:00 UTC
-
New cell infusion aims to prepare leukemia patients for life-saving transplant
Disease control Recruiting nowThis early-phase study tests whether adding a special type of immune cell infusion to chemotherapy can safely help prepare people with relapsed or refractory leukemia for a stem cell transplant. Only 5 participants will be enrolled to check for side effects like graft-versus-host…
Matched conditions: REFRACTORY LEUKEMIA
Phase: PHASE1 • Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo therapy targets Hard-to-Treat leukemias
Disease control Recruiting nowThis study tests whether combining two drugs, revumenib and mezigdomide, is safe for people with certain types of acute leukemia that have come back or not responded to treatment. The trial includes about 52 participants aged 12 and older with specific genetic changes in their le…
Matched conditions: REFRACTORY LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New hope for tough leukemia: 3-Drug combo trial opens
Disease control Recruiting nowThis study tests a combination of three drugs (venetoclax, chidamide, and azacitidine) in adults whose acute myeloid leukemia has returned or not responded to prior treatment. The goal is to see if this mix can safely achieve remission. About 30 participants will receive the trea…
Matched conditions: REFRACTORY LEUKEMIA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated May 01, 2026 16:00 UTC